GKSL Share Price | Gujarat Kidney & Super Speciality Ltd Stock Analysis & Recommendation

Q: Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

Based on the current analysis of Gujarat Kidney & Super Speciality Ltd, it would be advisable to hold your position in the company. The firm demonstrates a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.08 times. This indicates financial stability and a manageable debt load.While the company has shown some growth, with net sales increasing by 2.87% and a notable 58.01% growth in profit after tax over the last nine months, the overall long-term growth rates for net sales and operating profit are stagnant at 0%. This suggests that while recent results are positive, there may be challenges in sustaining growth moving forward.Additionally, the company has a return on equity (ROE) of 6.1, which, combined with a price-to-book value of 4.2, indicates that the stock may be considered expensive at its current valuation. Given these factors, maintaining your investment while monitoring the company's performance and market conditions seems to be the most prudent approach at this time.

Q: What does Gujarat Kidney do?

Overview:Gujarat Kidney & Super Speciality Ltd operates in the hospital industry and is classified as a micro-cap company.History:The company was incorporated in 2019 under the name Vihaan Medicare Private Limited. It later changed its name to Gujarat Kidney and Super Speciality Private Limited, with the latest certificate of incorporation issued on September 13, 2023. The most recent quarterly results reported net sales and net profit for the period ending March 2026.Financial Snapshot:Net Sales: 31 Cr (Quarterly Results - Mar 2026) Net Profit: 5 Cr (Quarterly Results - Mar 2026) Market Cap: INR 1,016 Cr (Micro Cap)Key Metrics:P/E: 63.00 Industry P/E: 60 Dividend Yield: 0.00% Debt Equity: -0.11 Return on Equity: 6.14% Price to Book: 4.06 Contact Details:No Company Details Available Registrar Address: Not available.

Mojo Score Change: Gujarat Kidney has changed its score on 09 Jul 2026. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

29.69 k (-83.75%) Volume

Shareholding (Mar 2026)

FII

4.88%

Held by 12 FIIs

DII

0.56%

Held by 0 DIIs

Promoter

71.45%

Why is Gujarat Kidney & Super Speciality Ltd falling/rising?

20-Jul-2026

As of 19-Jul, the stock price of Gujarat Kidney & Super Speciality Ltd is declining, currently at 128.55, with a total drop of 4.33% over the last four days. Investor participation has decreased significantly, indicating reduced interest, while the stock remains above long-term moving averages but below short-term ones, suggesting weakening momentum.

View full answer

Which are the latest news on Gujarat Kidney?

20-Jul-2026

Gujarat Kidney & Super Speciality Ltd Shows Technical Momentum Shift Amid Micro-Cap Hospital Sector
Gujarat Kidney & Super Speciality Ltd Upgraded to Hold on Improved Technicals and Financials

Should I buy, sell or hold Gujarat Kidney & Super Speciality Ltd?

10-Jul-2026

What does Gujarat Kidney do?

11-Jun-2026

Gujarat Kidney & Super Speciality Ltd, a micro-cap company incorporated in 2019, operates in the hospital industry and reported net sales of 31 Cr and a net profit of 5 Cr for the quarter ending March 2026. Key metrics include a P/E ratio of 63.00 and a market cap of INR 1,016 Cr.

View full answer

How big is Gujarat Kidney?

11-Jun-2026

As of 10th June, Gujarat Kidney & Super Speciality Ltd has a market capitalization of 1,016.00 Cr, with Net Sales of 82.02 Cr and a Net Profit of 15.49 Cr reported in the latest four quarters.

View full answer

Who are the peers of the Gujarat Kidney?

11-Jun-2026

Peers of Gujarat Kidney include Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Shalby, and others. KMC Speciality leads in 1-year returns at 75.31%, while Indrapr.Medical has the lowest at -9.19%.

View full answer

When is the next results date for Gujarat Kidney & Super Speciality Ltd?

12-Feb-2026

The next results date for Gujarat Kidney & Super Speciality Ltd is 14 February 2026.

View full answer

Compare Gujarat Kidney with Similar Stocks

Unihealth Hosp Chandan Healthca GPT Healthcare

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.08 times

Healthy long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0%

With a growth in Net Sales of 2.87%, the company declared Very Positive results in Mar 26

With ROE of 6.1, it has a Very Expensive valuation with a 4 Price to Book Value

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Hospital

Market cap

INR 1,004 Cr (Micro Cap)

P/E

65.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.11

Return on Equity

6.14%

Price to Book

4.01

Revenue and Profits:

Net Sales:

31 Cr

(Quarterly Results - Mar 2026)

Net Profit:

5 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

13.13%

6 Months

23.43%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

Gujarat Kidney for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

Gujarat Kidney & Super Speciality Ltd Shows Technical Momentum Shift Amid Micro-Cap Hospital Sector

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by a series of technical indicator signals and price action that suggest improving investor sentiment and potential for further gains.

Read full news article

Gujarat Kidney & Super Speciality Ltd Upgraded to Hold on Improved Technicals and Financials

Gujarat Kidney & Super Speciality Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in technical indicators and solid financial performance. The company’s Mojo Score rose to 52.0, signalling a more balanced outlook amid a micro-cap hospital sector environment. This upgrade follows a comprehensive reassessment across quality, valuation, financial trends, and technical parameters, highlighting both opportunities and challenges for investors.

Read full news article

Gujarat Kidney & Super Speciality Ltd Sees Technical Momentum Shift Amid Sideways Trend

Gujarat Kidney & Super Speciality Ltd, a micro-cap player in the hospital sector, has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced outlook for investors amid recent price movements.

Read full news article

Announcements

No announcement available

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

12.54

Debt to EBITDA (avg)

0.92

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.74

Tax Ratio

20.82%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

5.44%

ROCE (avg)

26.45%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.01

EV to EBIT

44.26

EV to EBITDA

36.54

EV to Capital Employed

4.37

EV to Sales

12.00

PEG Ratio

Dividend Yield

ROCE (Latest)

9.87%

ROE (Latest)

6.14%

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

No Signal

Bollinger Bands

Mildly Bullish

KST

Dow Theory

Mildly Bullish

No Trend

OBV

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.0%)

FIIs

Held by 12 FIIs (4.88%)

Promoter with highest holding

Pragnesh Yashwantsinh Bharpoda (38.16%)

Highest Public shareholder

Khandelwal Finance Private Limited (1.67%)

Individual Investors Holdings

10.64%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -5.33% vs 1.24% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -41.20% vs 1.30% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.24",
          "val2": "9.76",
          "chgp": "-5.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.57",
          "val2": "4.14",
          "chgp": "-62.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.29",
          "chgp": "72.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.37",
          "val2": "2.33",
          "chgp": "-41.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.99%",
          "val2": "42.42%",
          "chgp": "-25.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.09",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10.42",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.20",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.41%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.85",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.56",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.65",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.53",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "47.20%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.10",
          "val2": "35.17",
          "chgp": "14.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.14",
          "val2": "15.45",
          "chgp": "4.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.15",
          "val2": "0.53",
          "chgp": "116.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.90",
          "val2": "9.11",
          "chgp": "8.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.25%",
          "val2": "43.93%",
          "chgp": "-3.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

9.24

9.76

-5.33%

Operating Profit (PBDIT) excl Other Income

1.57

4.14

-62.08%

Interest

0.50

0.29

72.41%

Exceptional Items

0.00

Standalone Net Profit

1.37

2.33

-41.20%

Operating Profit Margin (Excl OI)

16.99%

42.42%

-25.43%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -5.33% vs 1.24% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -41.20% vs 1.30% in Dec 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Change(%)

Net Sales

21.09

Operating Profit (PBDIT) excl Other Income

10.42

Interest

0.36

Exceptional Items

0.00

Standalone Net Profit

6.20

Operating Profit Margin (Excl OI)

49.41%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Change(%)

Net Sales

30.85

Operating Profit (PBDIT) excl Other Income

14.56

Interest

0.65

Exceptional Items

0.00

Standalone Net Profit

8.53

Operating Profit Margin (Excl OI)

47.20%

NA%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

40.10

35.17

14.02%

Operating Profit (PBDIT) excl Other Income

16.14

15.45

4.47%

Interest

1.15

0.53

116.98%

Exceptional Items

0.00

Standalone Net Profit

9.90

9.11

8.67%

Operating Profit Margin (Excl OI)

40.25%

43.93%

-3.68%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Results

Company CV

About Gujarat Kidney & Super Speciality Ltd

Gujarat Kidney & Super Speciality Ltd

Micro Cap

Hospital

Gujarat Kidney And Super Speciality Limited was incorporated under the name and style of `Vihaan Medicare Private Limited', a private limited company, dated December 20, 2019 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the Company name was changed to `Gujarat Kidney and Super Speciality Private Limited' and a fresh certificate of incorporation dated September 13, 2023 was issued by the Registrar of Companies, Gujarat at Ahmedabad.

Company Coordinates

No Company Details Available